216 related articles for article (PubMed ID: 35853412)
1. Generation of human induced pluripotent stem cell lines carrying heterozygous PLN mutation from dilated cardiomyopathy patients.
Caudal A; Mondejar-Parreño G; Vera CD; Williams DR; Shenoy SP; Liang D; Wu JC
Stem Cell Res; 2022 Aug; 63():102855. PubMed ID: 35853412
[TBL] [Abstract][Full Text] [Related]
2. Modeling of dilated cardiomyopathy by establishment of isogenic human iPSC lines carrying phospholamban C25T (R9C) mutation (UPITTi002-A-1) using CRISPR/Cas9 editing.
Barndt RJ; Ma N; Tang Y; Haugh MP; Alamri LS; Chan SY; Wu H
Stem Cell Res; 2021 Oct; 56():102544. PubMed ID: 34583280
[TBL] [Abstract][Full Text] [Related]
3. Generation of human induced pluripotent stem cell (iPSC) lines derived from five patients carrying the pathogenic phospholamban-R14del (PLN-R14del) variant and three non-carrier family members.
Mittal N; Dave J; Harakalova M; van Tintelen JP; Asselbergs FW; Doevendans PA; Costa KD; Turnbull IC; Stillitano F
Stem Cell Res; 2022 Apr; 60():102737. PubMed ID: 35247838
[TBL] [Abstract][Full Text] [Related]
4. Generation of two induced pluripotent stem cell lines from dilated cardiomyopathy patients carrying heterozygous FLNC mutations.
Kojic A; Kim H; Guevara JV; Ravada S; Sallam K; Wu JC
Stem Cell Res; 2022 Oct; 64():102928. PubMed ID: 36194907
[TBL] [Abstract][Full Text] [Related]
5. Generation of two induced pluripotent stem cell lines from dilated cardiomyopathy patients carrying TTN mutations.
Zhang TT; Zhao SR; Alamana C; Shen M; Parikh V; Wheeler MT; Wu JC
Stem Cell Res; 2022 Dec; 65():102941. PubMed ID: 36270069
[TBL] [Abstract][Full Text] [Related]
6. Establishment of a human iPSC (ZZUNEUi026-A) from a dilated cardiomyopathy patient carrying heterozygous Vinculin (c. 625A > T) mutant.
Liu Y; Li X; Zhao X; Dong J; Zhang C; Lin T
Stem Cell Res; 2022 Jul; 62():102812. PubMed ID: 35567849
[TBL] [Abstract][Full Text] [Related]
7. Generation of a heterozygous FLNC mutation-carrying human iPSC line, USFi002-A, for modeling dilated cardiomyopathy.
Argenziano MA; Burgos Angulo M; Najari Beidokhti M; Yang J; Bertalovitz AC; McDonald TV
Stem Cell Res; 2021 May; 53():102394. PubMed ID: 34088019
[TBL] [Abstract][Full Text] [Related]
8. Generation of human induced pluripotent stem cell line EURACi015-A from a patient affected by dilated cardiomyopathy carrying the Lamin A/C p.Glu161Lys mutation.
Cattelan G; Sophie Frommelt L; Volani C; Colliva A; Ciucci G; Paldino A; Dal Ferro M; Di Segni M; Silipigni R; Pramstaller PP; De Bortoli M; Zacchigna S; Rossini A
Stem Cell Res; 2023 Sep; 71():103172. PubMed ID: 37535990
[TBL] [Abstract][Full Text] [Related]
9. Generation of two induced pluripotent stem cell lines from dilated cardiomyopathy patients caused by heterozygous mutations in the HCN4 gene.
Yildirim Z; Kojic A; Yan CD; Wu MA; Vagelos R; Wu JC
Stem Cell Res; 2022 Dec; 65():102951. PubMed ID: 36332467
[TBL] [Abstract][Full Text] [Related]
10. Generation of human induced pluripotent stem cell lines derived from four patients with a pathogenic ALPK3 variant associated with adult-onset hypertrophic cardiomyopathy (HCM).
Cheawsamoot C; Ramchandani R; Ameen M; Arthur Ataam J; Khongphatthanayothin A; Shotelersuk V; Karakikes I
Stem Cell Res; 2023 Dec; 73():103233. PubMed ID: 37944352
[TBL] [Abstract][Full Text] [Related]
11. Generation of a patient-specific iPSC cell line with cardiac arrhythmias and dilated cardiomyopathy (CBRCULi016-A), an isogenic control (CBRCULi016-A-1), and a paternal control (CBRCULi017-A).
Djemai M; Jauvin D; Poulin H; Chapotte-Baldacci CA; Chahine M
Stem Cell Res; 2024 Mar; 75():103308. PubMed ID: 38232626
[TBL] [Abstract][Full Text] [Related]
12. Generation of a hiPSC line ZZUNEUi017-A from a patient with dilated cardiomyopathy caused by mutation in TTN.
Huang S; Fu W; Guo G; Tiana X; Zhao X; Dong J; Li X; Yang H
Stem Cell Res; 2021 Apr; 52():102248. PubMed ID: 33610015
[TBL] [Abstract][Full Text] [Related]
13. Generation and characterization of novel human induced pluripotent stem cell (iPSC) lines originating from five asymptomatic individuals carrying the PLN-R14del pathogenic variant and a non-carrier relative.
Balducci V; Scardigli F; Harakalova M; Peter van Tintelen J; Doevendans PA; Costa KD; Turnbull IC; P G Sluijter J; Stillitano F
Stem Cell Res; 2023 Oct; 72():103208. PubMed ID: 37748331
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the PLN p.Arg14del Mutation in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Badone B; Ronchi C; Lodola F; Knaust AE; Hansen A; Eschenhagen T; Zaza A
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948294
[TBL] [Abstract][Full Text] [Related]
15. Human induced pluripotent stem cell line YCMi007-A generated from a dilated cardiomyopathy patient with a heterozygous dominant c.613C > T (p. Arg205Trp) variant of the TNNT2 gene.
Jeon SB; Kim H; Chun KH; Oh J; Kwon C; Choi HK; Kim S; Kim HP; Kim IC; Yoo JY; Park SW; Kang SM; Lee SH
Stem Cell Res; 2023 Mar; 67():103048. PubMed ID: 36801602
[TBL] [Abstract][Full Text] [Related]
16. Generation of an induced pluripotent stem cell line (SDASi001-A) from a Schimke immune-osseous dysplasia patient with SMARCAL1 mutations.
Wang X; Zhang H; Wang X; Zhou W; Dong L; Li N; He Q
Stem Cell Res; 2023 Oct; 72():103217. PubMed ID: 37788557
[TBL] [Abstract][Full Text] [Related]
17. Generation of two iPSC lines (FAMRCi006-A and FAMRCi006-B) from patient with dilated cardiomyopathy and Emery-Dreifuss muscular dystrophy associated with genetic variant LMNAp.Arg527Pro.
Perepelina K; Klauzen P; Khudiakov A; Zlotina A; Fomicheva Y; Rudenko D; Gordeev M; Sergushichev A; Malashicheva A; Kostareva A
Stem Cell Res; 2020 Mar; 43():101714. PubMed ID: 32059175
[TBL] [Abstract][Full Text] [Related]
18. Generation of three iPSC lines from dilated cardiomyopathy patients carrying a pathogenic LMNA variant.
Lee C; Cho S; Lai C; Shenoy S; Vagelos R; Wu JC
Stem Cell Res; 2022 Mar; 59():102638. PubMed ID: 34954454
[TBL] [Abstract][Full Text] [Related]
19. Generation of human induced pluripotent stem cell lines derived from three Noonan syndrome patients from a single family carrying the heterozygous PTPN11 c.188 A > G (p.Y63C) mutation.
Sbrini G; Tomasoni Z; Cutrì MR; Pilotta A; Mingotti C; Badolato R; La Via L; Barbon A; Bono F; Fiorentini C
Stem Cell Res; 2024 Feb; 74():103293. PubMed ID: 38160629
[TBL] [Abstract][Full Text] [Related]
20. Heterozygous LMNA mutation-carrying iPSC lines from three cardiac laminopathy patients.
Cho S; Lee C; Lai C; Zhuge Y; Haddad F; Fowler M; Sallam K; Wu JC
Stem Cell Res; 2022 Mar; 59():102657. PubMed ID: 34999423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
